Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice

Scott G. Kitchen, Michael Bennett, Zoran Galić, Joanne Kim, Qing Xu, Alan Young, Alexis Lieberman, Aviva Joseph, Harris Goldstein, Hwee Ng, Otto Yang, Jerome A. Zack

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

There is a desperate need for effective therapies to fight chronic viral infections. The immune response is normally fastidious at controlling the majority of viral infections and a therapeutic strategy aimed at reestablishing immune control represents a potentially powerful approach towards treating persistent viral infections. We examined the potential of genetically programming human hematopoietic stem cells to generate mature CD8+ cytotoxic T lymphocytes that express a molecularly cloned, ''transgenic'' human anti-HIV T cell receptor (TCR). Anti-HIV TCR transduction of human hematopoietic stem cells directed the maturation of a large population of polyfunctional, HIV-specific CD8+ cells capable of recognizing and killing viral antigen-presenting cells. Thus, through this proof-of-concept we propose that genetic engineering of human hematopoietic stem cells will allow the tailoring of effector T cell responses to fight HIV infection or other diseases that are characterized by the loss of immune control.

Original languageEnglish (US)
Article numbere8208
JournalPLoS One
Volume4
Issue number12
DOIs
StatePublished - 2009

Fingerprint

T-cells
Hematopoietic Stem Cells
Stem cells
engineering
Virus Diseases
T-lymphocytes
T-Cell Antigen Receptor
antigens
T-Lymphocytes
Antigens
mice
HIV
Genetic engineering
Viral Antigens
infection
therapeutics
receptors
cytotoxic T-lymphocytes
Genetic Engineering
antigen-presenting cells

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Kitchen, S. G., Bennett, M., Galić, Z., Kim, J., Xu, Q., Young, A., ... Zack, J. A. (2009). Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice. PLoS One, 4(12), [e8208]. https://doi.org/10.1371/journal.pone.0008208

Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice. / Kitchen, Scott G.; Bennett, Michael; Galić, Zoran; Kim, Joanne; Xu, Qing; Young, Alan; Lieberman, Alexis; Joseph, Aviva; Goldstein, Harris; Ng, Hwee; Yang, Otto; Zack, Jerome A.

In: PLoS One, Vol. 4, No. 12, e8208, 2009.

Research output: Contribution to journalArticle

Kitchen, SG, Bennett, M, Galić, Z, Kim, J, Xu, Q, Young, A, Lieberman, A, Joseph, A, Goldstein, H, Ng, H, Yang, O & Zack, JA 2009, 'Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice', PLoS One, vol. 4, no. 12, e8208. https://doi.org/10.1371/journal.pone.0008208
Kitchen, Scott G. ; Bennett, Michael ; Galić, Zoran ; Kim, Joanne ; Xu, Qing ; Young, Alan ; Lieberman, Alexis ; Joseph, Aviva ; Goldstein, Harris ; Ng, Hwee ; Yang, Otto ; Zack, Jerome A. / Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice. In: PLoS One. 2009 ; Vol. 4, No. 12.
@article{5e311b166f27486da2f851903514e35a,
title = "Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice",
abstract = "There is a desperate need for effective therapies to fight chronic viral infections. The immune response is normally fastidious at controlling the majority of viral infections and a therapeutic strategy aimed at reestablishing immune control represents a potentially powerful approach towards treating persistent viral infections. We examined the potential of genetically programming human hematopoietic stem cells to generate mature CD8+ cytotoxic T lymphocytes that express a molecularly cloned, ''transgenic'' human anti-HIV T cell receptor (TCR). Anti-HIV TCR transduction of human hematopoietic stem cells directed the maturation of a large population of polyfunctional, HIV-specific CD8+ cells capable of recognizing and killing viral antigen-presenting cells. Thus, through this proof-of-concept we propose that genetic engineering of human hematopoietic stem cells will allow the tailoring of effector T cell responses to fight HIV infection or other diseases that are characterized by the loss of immune control.",
author = "Kitchen, {Scott G.} and Michael Bennett and Zoran Galić and Joanne Kim and Qing Xu and Alan Young and Alexis Lieberman and Aviva Joseph and Harris Goldstein and Hwee Ng and Otto Yang and Zack, {Jerome A.}",
year = "2009",
doi = "10.1371/journal.pone.0008208",
language = "English (US)",
volume = "4",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "12",

}

TY - JOUR

T1 - Engineering antigen-specific T cells from genetically modified human hematopoietic stem cells in immunodeficient mice

AU - Kitchen, Scott G.

AU - Bennett, Michael

AU - Galić, Zoran

AU - Kim, Joanne

AU - Xu, Qing

AU - Young, Alan

AU - Lieberman, Alexis

AU - Joseph, Aviva

AU - Goldstein, Harris

AU - Ng, Hwee

AU - Yang, Otto

AU - Zack, Jerome A.

PY - 2009

Y1 - 2009

N2 - There is a desperate need for effective therapies to fight chronic viral infections. The immune response is normally fastidious at controlling the majority of viral infections and a therapeutic strategy aimed at reestablishing immune control represents a potentially powerful approach towards treating persistent viral infections. We examined the potential of genetically programming human hematopoietic stem cells to generate mature CD8+ cytotoxic T lymphocytes that express a molecularly cloned, ''transgenic'' human anti-HIV T cell receptor (TCR). Anti-HIV TCR transduction of human hematopoietic stem cells directed the maturation of a large population of polyfunctional, HIV-specific CD8+ cells capable of recognizing and killing viral antigen-presenting cells. Thus, through this proof-of-concept we propose that genetic engineering of human hematopoietic stem cells will allow the tailoring of effector T cell responses to fight HIV infection or other diseases that are characterized by the loss of immune control.

AB - There is a desperate need for effective therapies to fight chronic viral infections. The immune response is normally fastidious at controlling the majority of viral infections and a therapeutic strategy aimed at reestablishing immune control represents a potentially powerful approach towards treating persistent viral infections. We examined the potential of genetically programming human hematopoietic stem cells to generate mature CD8+ cytotoxic T lymphocytes that express a molecularly cloned, ''transgenic'' human anti-HIV T cell receptor (TCR). Anti-HIV TCR transduction of human hematopoietic stem cells directed the maturation of a large population of polyfunctional, HIV-specific CD8+ cells capable of recognizing and killing viral antigen-presenting cells. Thus, through this proof-of-concept we propose that genetic engineering of human hematopoietic stem cells will allow the tailoring of effector T cell responses to fight HIV infection or other diseases that are characterized by the loss of immune control.

UR - http://www.scopus.com/inward/record.url?scp=77949515006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949515006&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0008208

DO - 10.1371/journal.pone.0008208

M3 - Article

C2 - 19997617

AN - SCOPUS:77949515006

VL - 4

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 12

M1 - e8208

ER -